Ocular Therapeutix, Inc. (OCUL)
10.78
-0.30
(-2.66%)
USD |
NASDAQ |
Aug 24, 16:00
10.78
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Total Assets (Quarterly) : 671.32M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 671.32M |
| March 31, 2026 | 732.53M |
| December 31, 2025 | 811.14M |
| September 30, 2025 | 410.88M |
| June 30, 2025 | 451.33M |
| March 31, 2025 | 405.92M |
| December 31, 2024 | 457.94M |
| September 30, 2024 | 490.37M |
| June 30, 2024 | 517.09M |
| March 31, 2024 | 538.95M |
| December 31, 2023 | 252.06M |
| September 30, 2023 | 162.38M |
| June 30, 2023 | 122.56M |
| March 31, 2023 | 128.57M |
| December 31, 2022 | 149.29M |
| September 30, 2022 | 158.58M |
| June 30, 2022 | 173.07M |
| March 31, 2022 | 187.62M |
| December 31, 2021 | 204.89M |
| September 30, 2021 | 217.74M |
| June 30, 2021 | 230.71M |
| March 31, 2021 | 243.04M |
| December 31, 2020 | 261.86M |
| September 30, 2020 | 98.22M |
| June 30, 2020 | 107.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 72.86M |
| December 31, 2019 | 78.74M |
| September 30, 2019 | 88.71M |
| June 30, 2019 | 89.74M |
| March 31, 2019 | 101.49M |
| December 31, 2018 | 73.04M |
| September 30, 2018 | 70.27M |
| June 30, 2018 | 70.46M |
| March 31, 2018 | 76.68M |
| December 31, 2017 | 55.43M |
| September 30, 2017 | 64.40M |
| June 30, 2017 | 79.68M |
| March 31, 2017 | 90.70M |
| December 31, 2016 | 74.94M |
| September 30, 2016 | 82.35M |
| June 30, 2016 | 89.90M |
| March 31, 2016 | 100.43M |
| December 31, 2015 | 110.31M |
| September 30, 2015 | 119.32M |
| June 30, 2015 | 129.47M |
| March 31, 2015 | 71.50M |
| December 31, 2014 | 78.19M |
| September 30, 2014 | 83.88M |
| June 30, 2014 | 23.97M |
| March 31, 2014 | 15.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| EyePoint, Inc. | 228.19M |
| LENZ Therapeutics, Inc. | 236.60M |
| Merck & Co., Inc. | 129.80B |
| Theravance Biopharma, Inc. | 469.77M |
| ANI Pharmaceuticals, Inc. | 1.494B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 151.28M |
| Shareholders Equity (Quarterly) | 520.04M |
| Debt to Equity Ratio | 0.1526 |
| Current Ratio | 13.10 |
| Net Debt Paydown Yield | -0.03% |